A team of researchers led by University of California, Riverside biomedical scientists has identified a small, previously ...
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results